Trials / Recruiting
RecruitingNCT06058442
The Pancreatic Enzymes After Gastrectomy Trial
- Status
- Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 188 (estimated)
- Sponsor
- University of Leipzig · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This trial evaluates the effects (e.g. on quality of life, weight) of NORTASE® compared to standard care of patients who have undergone gastrectomy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | NORTASE® | 10-15 capsules of NORTASE® per day - over 6 months |
| DRUG | Placebo | 10-15 capsules of placebo per day - over 6 months |
Timeline
- Start date
- 2024-01-24
- Primary completion
- 2027-06-01
- Completion
- 2027-06-01
- First posted
- 2023-09-28
- Last updated
- 2026-01-22
Locations
9 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT06058442. Inclusion in this directory is not an endorsement.